Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 941 of 1,261

  1. US 8080262

    Encapsulated peptide amphiphile nanostructures

    Northwestern University · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  2. US 8080256

    Endophytic fungi from Pteromischum sp. plant, compounds and methods of use

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  3. US 8080416

    Method for determining the immunogenicity of an antigen

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  4. US 8080248

    Method of treating rheumatoid arthritis with an IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  5. US 8080241

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  6. US 8080578

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  7. US 8080236

    Particulate materials

    Nektar Therapeutics UK, Ltd · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  8. US 8080526

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  9. US 8080579

    Compositions and methods for treatment of inflammatory bowel disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  10. US 8080584

    Delayed release rasagiline citrate formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  11. US 8080572

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  12. US 8080246

    Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  13. US 8080523

    Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  14. US 8076357

    Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  15. US 8075920

    Administration of cells and cellular extracts for rejuvenation

    REGENICS AS · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  16. US 8076304

    Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions

    The Regents of the University of Colorado · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  17. US 8076451

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  18. US 8076100

    Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  19. US 8075904

    High aspect ratio template and method for producing same for central and peripheral nerve repair

    The Regents of the University of California · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  20. US 8075903

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  21. US 8075887

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  22. US 8075900

    Melanoma associated peptide analogues and vaccines against melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  23. US 8075881

    Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure

    Regents of the University of Minnesota · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  24. US 8076470

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.